嘌呤能系统在精神疾病中的作用
本文综述嘌呤能系统在抑郁、精神分裂症、双相障碍、孤独症、焦虑及注意缺陷/多动障碍等精神疾病发生与易感中的作用,并描述精神疾病治疗药物如何作用于嘌呤能系统。
要点
- 嘌呤能系统参与多种精神疾病的生物学机制。
- 综述覆盖抑郁、精神分裂症、双相障碍、孤独症、焦虑及ADHD。
- 精神疾病治疗药物可作用于嘌呤能系统。
核心结论
- 嘌呤能系统与多种精神疾病的发生和易感性相关,且现有精神疾病治疗药物可作用于该系统。
研究设计与样本
- 综述,对嘌呤能系统在精神疾病发生与易感中作用及功能的文献进行了全面检索。
主要发现
- 综述聚焦抑郁、精神分裂症、双相障碍、孤独症、焦虑及注意缺陷/多动障碍。
- 文中描述了精神疾病治疗药物如何作用于嘌呤能系统。
临床怎么用
- 精神科临床可关注嘌呤能系统作为精神疾病生物学机制及治疗靶点的潜在相关性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psychiatric disorders are debilitating diseases, affecting >80 million people worldwide. There are no causal cures for psychiatric disorders and available therapies only treat the symptoms. The etiology of psychiatric disorders is unknown, although it has been speculated to be a combination of environmental, stress and genetic factors. One of the neurotransmitter systems implicated in the biology of psychiatric disorders is the purinergic system. In this review, we performed a comprehensive search of the literature about the role and function of the purinergic system in the development and predisposition to psychiatric disorders, with a focus on depression, schizophrenia, bipolar disorder, autism, anxiety and attention deficit/hyperactivity disorder. We also describe how therapeutics used for psychiatric disorders act on the purinergic system.
引用
- Cheffer A, Castillo ARG, Corrêa-Velloso J, et al. Purinergic system in psychiatric diseases. Mol Psychiatry. 2017. PMID: 28948971. doi:10.1038/mp.2017.188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。